Authors:
Niklinski, J
Niklinska, W
Chyczewski, L
Becker, HD
Pluygers, E
Citation: J. Niklinski et al., Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications, EUR J CAN P, 10(3), 2001, pp. 213-226
Authors:
Laudanski, J
Niklinska, W
Burzykowski, T
Chyczewski, L
Niklinski, J
Citation: J. Laudanski et al., Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer, EUR RESP J, 17(4), 2001, pp. 660-666
Authors:
Kasacka, I
Humenczyk-Zybala, M
Debek, W
Chyczewski, L
Niczyporuk, M
Mycko, G
Citation: I. Kasacka et al., The evaluation of murine pleural lavage fluid cellular composition in experimental hemorrhagic shock with special regard to mast cells morphometry, J PHYSL PH, 52(2), 2001, pp. 293-301
Authors:
Sulkowska, M
Famulski, W
Chyczewski, L
Sulkowski, S
Citation: M. Sulkowska et al., Evaluation of p53 and Bcl-2 oncoprotein expression in precancerous lesionsof the oral cavity, NEOPLASMA, 48(2), 2001, pp. 94-98
Authors:
Niklinska, W
Burzykowski, T
Chyczewski, L
Rusin, MR
Furman, M
Laudanski, J
Chyczewska, E
Sulik, M
Niklinski, J
Citation: W. Niklinska et al., p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland, EUR J CAN P, 9(2), 2000, pp. 81-87
Authors:
Wereszczynska-Siemiatkowska, U
Dlugosz, JW
Siemiatkowski, A
Chyczewski, L
Gabryelewicz, A
Citation: U. Wereszczynska-siemiatkowska et al., Lysosomal activity of pulmonary alveolar macrophages in acute experimentalpancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect, EXP TOX PAT, 52(2), 2000, pp. 119-125
Authors:
Laudanski, J
Chyczewski, L
Niklinska, WE
Kretowska, M
Furman, M
Sawicki, B
Niklinski, J
Citation: J. Laudanski et al., Expression of bcl-2 protein in non-small cell lung cancer: Correlation with clinicopathology and patient survival, NEOPLASMA, 46(1), 1999, pp. 25-30
Authors:
Niklinski, J
Burzykowski, T
Niklinska, W
Laudanski, J
Chyczewski, L
Rapellino, M
Furman, M
Citation: J. Niklinski et al., Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer, EUR RESP J, 12(6), 1998, pp. 1424-1428
Authors:
Laudanski, J
Burzykowski, T
Niklinska, W
Chyczewski, L
Furman, M
Niklinski, J
Citation: J. Laudanski et al., Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer, LUNG CANC, 22(3), 1998, pp. 191-200